Skip to main content Accessibility help
×
Home
  • Print publication year: 2010
  • Online publication date: January 2011

Section 2 - The assessment of pain

References

1. Von Roenn JH, Cleeland CS, Gonin R, Hatfield AK, Pandya KJ. Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group. Ann Intern Med 1993; 119: 121–6.
2. Chisholm CD, Weaver CS, Whenmouth LF, Giles B, Brizendine EJ. A comparison of observed versus documented physician assessment and treatment of pain: the physician record does not reflect the reality. Ann Emerg Med 2008; 52: 383–9.
3. Melzack R, Wall PD. Pain mechanisms: a new theory. Science 1965; 150: 971–9.
4. Melzack, R. Pain: past, present and future. Can J Exp Psychol 1993; 47: 615–29.
5. Gatchel, RJ, Turk, DC. Psychological Approaches to Pain Management: A practitioner’s handbook (New York: Guilford Press, 1996).
6. Fuchs-Lacelle S, Hadjistavropoulos T, Lix L. Pain assessment as intervention: A study of older adults with severe dementia. Clin J Pain 2008; 24: 697–707.
7. Dworkin RH, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain 2008; 9: 105–21.
8. Abbo ED, Zhang Q, Zelder M, Huang ES. The increasing number of clinical items addressed during the time of adult primary care visits. J Gen Intern Med 2008; 23: 2058–65.
9. Turk, DC, Okifuji A. Assessment of patients’ reporting of pain: an integrated perspective. Lancet 1999; 353: 1784–8.
10. Chapman, CR, New Joint Commission standards for pain management: Carpe diem. APS Bulletin 2000; 10: 3.
11. Jensen, MP, Karoly, P. Self-report scales and procedures for assessing pain in adults. In Handbook of Pain Assessment, 2nd edn, eds. DC Turk and R Melzack. (New York: Guilford Press, 2001).
12. Verbunt JA, Seelen HA, Vlaeyen JW, et al. The effect of chronic pain on diabetes patients’ self-management. Diabetes Care 2005; 28: 65–70.
13. Verbunt JA, Seelen HA, Vlaeyen JW, et al. Disuse and deconditioning in chronic low back pain: Concepts and hypotheses on contributing mechanisms. Eur J Pain 2003: 7: 9–21.
14. Pollard, CA. Preliminary validity study of the pain disability index. Percept Mot Skills 1984; 59: 974.
15. Tait, RC, Chibnall, JT, Krause, S. The Pain Disability Index: Psychometric properties. Pain 1990; 40: 171–82.
16. Grönblad M, Järvinen E, Hurri H, Hupli M, Karaharju EO. Relationship of the Pain Disability Index (PDI) and the Oswestry Disability Questionnaire (ODQ) with three dynamic physical tests in a group of patients with chronic low-back and leg pain. Clin J Pain 1994; 10: 197–203.
17. Roland, M, Morris, R. A study of the natural history of back pain. Part I: development of a reliable and sensitive measure of disability in low-back pain. Spine; 1983; 8: 141–4.
18. Cleeland, CS, Ryan, KM. Pain assessment: Global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994; 23: 129–38.
19. Keller S, Bann CM, Dodd SL, et al. Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain 2004; 20: 309–18.
20. Kori KS, Miller RP, Todd DD. Kinesiophobia: A new view of chronic pain behavior. Pain Management 1990; 3: 35–43.
21. French DJ, France CR, Vigneau F, French JA, Evans RT. Fear of movement/(re)injury in chronic pain: A psychometric assessment of the original English version of the Tampa scale for kinesiophobia (TSK). Pain 2007; 127: 42–51.
22. Willoughby SG, Hailey BJ, Mulkana S, Rowe J. The effect of laboratory-induced depressed mood state on responses to pain. Behav Med 2002; 28: 23–31.
23. Alden AL, Dale JA, DeGood DE. Interactive effects of the affect quality and directional focus of mental imagery on pain analgesia. Appl Psychophysiol Biofeedback 2001; 26: 117–26.
24. al Absi M, Rokke PD. Can anxiety help us tolerate pain? Pain 1991; 46: 43–51.
25. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561–71.
26. Beck AT, Steer, RA, Garbin, MG. Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clin Psychol Rev 1988; 8: 77–100.
27. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982; 17: 37–49.
28. Brink, TA, Yesavage, JA, Lum, O, et al. Screening tests for geriatric depression. Clin Gerontologist 1982; 1: 37–43.
29. McCracken, LM, Zayfert C, Gross RT. The Pain Anxiety Symptoms Scale: development and validation of a scale to measure fear of pain. Pain 1992; 50: 67–73.
30. McCracken, LM, Faber SD, Janeck AS. Pain-related anxiety predicts non-specific physical complaints in persons with chronic pain. Behav Res Ther 1998; 36: 621–30.
31. Spielberger CD, Gorsuch, RL, Lushene R. Manual for the State-Trait Anxiety Inventory (Palo Alto: Consulting Psychologists Press, 1970).
32. Speilberger CD, Gorsuch, RL, Lushene R, Vagg PR, Jacobs, GA, Manual for the State-Trait Anxiety Inventory (Form Y) (Palo Alto: Consulting Psychologists Press, 1983).
33. Bradley LA, Young LD, Anderson KO, et al. Effects of psychological therapy on pain behavior of rheumatoid arthritis patients. Treatment outcome and six-month followup. Arthritis Rheum 1987; 30: 1105–14.
34. Melzack R. The McGill Pain Questionnaire: Major properties and scoring methods. Pain 1975; 1: 277–99.
35. Jensen MP. The validity and reliability of pain measures for use in clinical trials in adults. In Initiative on Methods, Measurement, and Pain Assessment in Clincal Trials (IMMPACT). 2003.
36. Jensen MP, Karoly P, Harris P. Assessing the affective component of chronic pain: Development of the Pain Discomfort Scale. J Psychosom Res 1991; 35: 149–54.
37. Kerns RD, Turk DC, Rudy TE. The West Haven-Yale Multidimensional Pain Inventory (WHYMPI). Pain 1985; 23: 345–56.
38. Ware JE, Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473–83.
39. McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994; 32: 40–66.
40. McHorney CA, Ware, JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993; 31: 247–63.
41. Wittink H, Turk DC, Carr DB, Sukiennik A, Rogers W. Comparison of the redundancy, reliability, and responsiveness to change among SF-36, Oswestry Disability Index, and Multidimensional Pain Inventory. Clin J Pain 2004; 20: 133–42.
42. Millon T, Green, CJ, Meagher R. Millon Behavioral Health Inventory Manual. 3rd edn.(Minneapolis: National Computer Systems, 1983).
43. Gatchel RJ, Mayer TG, Capra P, Barnett J, Diamond P. Millon Behavioral Health Inventory: Its utility in predicting physical function in patients with low back pain. Arch Phys Med Rehabil 1986; 67: 878–82.
44. Jensen MP, Turner JA, Romano JM, Strom SE. The Chronic Pain Coping Inventory: Development and preliminary validation. Pain 1995; 60: 203–16.
45. Tan G, Nguyen Q, Anderson KO, Jensen M, Thornby J. Further validation of the chronic pain coping inventory. J Pain 2005; 6: 29–40.
46. Jensen MP, Karoly P, Huger R. The development and preliminary validation of an instrument to assess patients’ attitudes toward pain. J Psychosom Res 1987; 31: 393–400.
47. Jensen MP, Turner JA, Romano JM, Lawler BK. Relationship of pain-specific beliefs to chronic pain adjustment. Pain 1994; 57: 301–9.
48. Nielson, WR, Jensen MP, Kerns RD. Initial development and validation of a multidimensional pain readiness to change questionnaire. J Pain 2003; 4: 148–58.
49. Kerns RD, Rosenberg R, Jamison RN, Caudill MA, Haythornthwaite J. Readiness to adopt a self-management approach to chronic pain: The Pain Stages of Change Questionnaire (PSOCQ). Pain 1997; 72: 227–34.
50. Kerns RD, Habib S. A critical review of the pain readiness to change model. J Pain 2004; 5: 357–67.
51. Herr K, Coyne PJ, Key T, et al. Pain assessment in the nonverbal patient: Position statement with clinical practice recommendations. Pain Manag Nurs 2006; 7: 44–52.
52. Stinson JN, Kavanagh T, Yamada J, Gill N, Stevens B. Systematic review of the psychometric properties, interpretability and feasibility of self-report pain intensity measures for use in clinical trials in children and adolescents. Pain 2006; 125: 143–57.
53. Hester NK. The preoperational child’s reaction to immunization. Nurs Res 1979; 28: 250–5.
54. Hicks CL, von Baeyer CL, Spafford PA, van Korlaar I, Goodenough B. The Faces Pain Scale-Revised: Toward a common metric in pediatric pain measurement. Pain 2001; 93: 173–83.
55. Wong DL, Baker CM. Pain in children: Comparison of assessment scales. Okla Nurse 1988; 33: 8.
56. Beyer JE, Aradine CR. Content validity of an instrument to measure young children’s perceptions of the intensity of their pain. J Pediatr Nurs 1986; 1: 386–95.
57. von Baeyer, CL, Spagrud LJ. Systematic review of observational (behavioral) measures of pain for children and adolescents aged 3 to 18 years. Pain 2007; 127: 140–50.
58. Merkel SI, Voepel-Lewis T, Shayevitz JR, Malviya S. The FLACC: A behavioral scale for scoring postoperative pain in young children. Pediatr Nurs 1997; 23: 293–7.
59. McGrath PJ, Johnson G, Goodman JT, et al. CHEOPS: A behavioral scale for rating postoperative pain in children. In Advances in Pain Research and Therapy, Vol. 9, eds. HL Fields, R Dubner and F Cervero (New York: Raven Press, 1985) pp. 395–402.
60. Chambers CT, Reid GJ, McGrath PJ, Finley GA Development and preliminary validation of a postoperative pain measure for parents. Pain 1996; 68: 307–13.
61. Ambuel B, Hamlett KW, Marx CM, Blumer JL. Assessing distress in pediatric intensive care environments: The COMFORT scale. J Pediatr Psychol 1992; 17: 95–109.
62. Savedra MC, Holzemer WL, Tesler MD, Wilkie DJ. Assessment of postoperation pain in children and adolescents using the adolescent pediatric pain tool. Nurs Res 1993; 42: 5–9.
63. LeBaron S, Zeltzer L. Assessment of acute pain and anxiety in children and adolescents by self-reports, observer reports, and a behavior checklist. J Consult Clin Psychol 1984; 52: 729–38.
64. McGrath PJ, Walco GA, Turk DC, et al. Core outcome domains and measures for pediatric acute and chronic/recurrent pain clinical trials: PedIMMPACT recommendations. J Pain 2008; 9: 771–83.
65. Ardery G, Herr KA, Titler MG, Sorofman BA, Schmitt MB. Assessing and managing acute pain in older adults: A research base to guide practice. Medsurg Nurs 2003; 12: 7–18; quiz 19.
66. Ferrell BA, Stein W, Beck JC. The Geriatric Pain Measure: Validity, reliability and factor analysis. J Am Geriatr Soc 2000; 48: 1669–73.
67. American Geriatrics Society. The management of persistent pain in older persons. J Am Geriatr Soc 2002; 50(6 Suppl): S205–24.
68. Fuchs-Lacelle S, Hadjistavropoulos T. Development and preliminary validation of the pain assessment checklist for seniors with limited ability to communicate (PACSLAC). Pain Manag Nurs 2004; 5: 37–49.
69. Lefebvre-Chapiro, S. The Dolophus group. The Dolophus 2 scale: Evaluating pain in the elderly. Eur J Pall Care 2001; 8: 191–4.
70. Feldt KS. The checklist of nonverbal pain indicators (CNPI). Pain Manag Nurs 2000; 1: 13–21.
71. Snow AL, Weber JB, O’Malley KJ, et al. NOPPAIN: A nursing assistant-administered pain assessment instrument for use in dementia. Dement Geriatr Cogn Disord 2004; 17: 240–6.
72. Li D, Puntillo K, Miaskowski C. A review of objective pain measures for use with critical care adult patients unable to self-report. J Pain 2008; 9: 2–10.
73. McCaffery M, Pasero C, eds. Assessment: Underlying complexities, misconceptions, and practical tools. Pain: Clinical manual 2nd edn. (Mosby: St. Louis, 1999).
74. Payen JF, Bru O, Bosson JL. et al. Assessing pain in critically ill sedated patients by using a behavioral pain scale. Crit Care Med 2001; 29: 2258–63.
75. Gélinas C, Fillion L, Puntillo KA, Viens C, Fortier M. Validation of the critical-care pain observation tool in adult patients. Am J Crit Care 2006; 15: 420–7.
76. Mateo OM, Krenzischek DA. A pilot study to assess the relationship between behavioral manifestations and self-report of pain in postanesthesia care unit patients. J Post Anesth Nurs 1992; 7: 15–21.
77. Puntillo KA, Miaskowski C, Kehrle K, et al. Relationship between behavioral and physiological indicators of pain, critical care patients’ self-reports of pain, and opioid administration. Crit Care Med 1997; 25: 1159–66.
78. Puntillo KA, Miaskowski C, Kehrle K, et al. Pain behaviors observed during six common procedures: Results from Thunder Project II. Crit Care Med 2004; 32: 421–7.
79. Nampiaparampil DE. Prevalence of chronic pain after traumatic brain injury: A systematic review. JAMA 2008; 300: 711–9.
80. Scherder E, Wolters E, Polman C, Sergeant J, Swaab D. Pain in Parkinson’s disease and multiple sclerosis: Its relation to the medial and lateral pain systems. Neurosci Biobehav Rev 2005; 29: 1047–56.
81. Warden V, Hurley AC, Volicer L. Development and psychometric evaluation of the Pain Assessment in Advanced Dementia (PAIN – AD) Scale. J Am Med Dir Assoc 2003; 4: 9–15.

References

1. Serlin RC, Mendoza TR, Nakamura Y, et al. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 1995; 61: 277–84.
2. Rudy TE, Lieber SJ, Boston JR, et al. Psychosocial predictors of physical performance in disabled individuals with chronic pain. Clin J Pain 2003; 19: 18–30.
3. Tyler EJ, Jensen MP, Engel JM, et al. The reliability and validity of pain interference measures in persons with cerebral palsy. Arch Phys Med Rehabil 2002; 83: 236–9.
4. Deshields TL, Tait RC, Gfeller JD, et al. Relationship between social desirability and self-report in chronic pain patients. Clin J Pain 1995; 11: 189–93.
5. de Bock GH, Hermans J, van Marwijk HW, et al. Health-related quality of life assessments in osteoarthritis during NSAID treatment. Pharm World Sci 1996; 18: 130–6.
6. Tait RC, Pollard CA, Margolis RB, et al. The Pain Disability Index: Psychometric and validity data. Arch Phys Med Rehabil 1987; 68: 438–41.
7. Daut RL, Cleeland CS, Flanery RC. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 1983; 17: 197–210.
8. Kerns R, Turk D, Rudy T. The West Haven-Yale Multidimensional Pain Inventory (WHYMPI). Pain 1985; 23: 345–56.
9. Bergner M, Bobbitt RA, Carter WB, et al. The sickness impact profile: Development and final revision of a health status measure. Med Care 1981; 19: 787–805.
10. Lousberg R, Van Breukelen GJ, Groenman NH, et al. Psychometric properties of the Multidimensional Pain Inventory, Dutch language version (MPI-DLV). Behav Res Ther 1999; 37: 167–82.
11. Schwarz N. Self-reports: How the questions shape the answers. Am Psychol 2003; 54: 93–105.
12. Anderson KO, Syrjala KL, Cleeland CS. How to assess cancer pain. In Handbook of Pain Assessment. 2nd edn, eds. DC Turk DC and R Melzack. (New York: Guilford Press, 2001), pp. 579–600.
13. Cleeland CS, Ryan KM. Pain assessment: Global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994; 23: 129–38.
14. Cleeland CS, Nakamura Y, Mendoza TR, et al. Dimensions of the impact of cancer pain in a four country sample: new information from multidimensional scaling. Pain 1996; 67: 267–73.
15. Portenoy RK, Miransky J, Thaler HT, et al. Pain in ambulatory patients with lung or colon cancer. Prevalence, characteristics, and effect. Cancer 1992; 70: 1616–24.
16. Radbruch L, Loick G, Kiencke P, et al. Validation of the German version of the Brief Pain Inventory. J Pain Symptom Manage 1999; 18: 180–7.
17. Owen JE, Klapow JC, Casebeer L. Evaluating the relationship between pain presentation and health-related quality of life in outpatients with metastatic or recurrent neoplastic disease. Qual Life Res 2000; 9: 855–63.
18. Smith MY, Egert J, Winkel G, et al. The impact of PTSD on pain experience in persons with HIV/AIDS. Pain 2002; 98: 9–17.
19. Hardy JR, Rees EA, Gwilliam B, et al. A phase II study to establish the efficacy and toxicity of sodium valproate in patients with cancer-related neuropathic pain. J Pain Symptom Manage 2001; 21: 204–9.
20. Wallace M, Rauck RL, Moulin D, et al. Conversion from standard opioid therapy to once-daily oral extended-release hydromorphone in patients with chronic cancer pain. J Int Med Res 2008; 36: 343–52.
21. White WT, Patel N, Drass M, et al. Lidocaine patch 5% with systemic analgesics such as gabapentin: A rational polypharmacy approach for the treatment of chronic pain. Pain Med 2003; 4: 321–30.
22. Du Pen SL, Du Pen AR, Polissar N, et al. Implementing guidelines for cancer pain management: Results of a randomized controlled clinical trial. J Clin Oncol 1999; 17: 361–70.
23. Schiffmann R, Kopp JB, Austin HA, III, et al. Enzyme replacement therapy in Fabry disease: A randomized controlled trial. JAMA 2001; 285: 2743–9.
24. Armstrong DG, Chappell AS, Le TK, et al. Duloxetine for the management of diabetic peripheral neuropathic pain: Evaluation of functional outcomes. Pain Med 2007; 8: 410–8.
25. Passard A, Attal N, Benadhira R, et al. Effects of unilateral repetitive transcranial magnetic stimulation of the motor cortex on chronic widespread pain in fibromyalgia. Brain 2007; 130: 2661–70.
26. Cowan DT, Wilson-Barnett DJ, Griffiths P, et al. A randomized, double-blind, placebo-controlled, cross-over pilot study to assess the effects of long-term opioid drug consumption and subsequent abstinence in chronic noncancer pain patients receiving controlled-release morphine. Pain Med 2005; 6: 113–21.
27. Evans S, Fishman B, Spielman L, et al. Randomized trial of cognitive behavior therapy versus supportive psychotherapy for HIV-related peripheral neuropathic pain. Psychosomatics 2003; 44: 44–50.
28. Ersek M, Turner JA, Cain KC, et al. Results of a randomized controlled trial to examine the efficacy of a chronic pain self-management group for older adults [ISRCTN11899548]. Pain 2008; 138: 29–40.
29. Rutledge DN, Jones CJ. Effects of topical essential oil on exercise volume after a 12-week exercise program for women with fibromyalgia: A pilot study. J Altern Complement Med 2007; 13: 1099–106.
30. Chibnall JT, Tait RC. The Pain Disability Index: Factor structure and normative data. Arch Phys Med Rehabil 1994; 75: 1082–6.
31. Arkinstall W, Sandler W, Goughnour B, et al. Efficacy of controlled-release codeine in chronic non-malignant pain: A randomized, placebo-controlled clinical trial. Pain 1995; 62: 169–78.
32. Jerome A, Gross RT. Pain disability index: Construct and discriminant validity. Arch Phys Med Rehabil 1991; 72: 920–2.
33. Gronblad MMD, Jarvinen EMS, Hurri HMD, et al. Relationship of the Pain Disability Index (PDI) and the Oswestry Disability Questionnaire (ODQ) with three dynamic physical tests in a group of patients with chronic low-back and leg pain. Clin J Pain 1994; 10: 197–203.
34. Harke H, Gretenkort P, Ladleif HU, et al. Spinal cord stimulation in postherpetic neuralgia and in acute herpes zoster pain. Anesth Analg 2002; 94: 694–700.
35. Eisenberg E, Lurie Y, Braker C, et al. Lamotrigine reduces painful diabetic neuropathy: A randomized, controlled study. Neurology 2001; 57: 505–9.
36. Harden RN, Brenman E, Saltz S, et al. Topiramate in the management of spinal cord injury pain: A double-blind, randomized, placeb-controlled pilot study. In Spinal Cord Injury: Assessment, mechanisms, management. 23rd edn, eds. RP Yezierski and KJ Burchiel. (Seattle: IASP Press, 2002), pp. 393–407.
37. Gronblad M, Hupli M, Wennerstrand P, et al. Intercorrelation and test-retest reliability of the Pain Disability Index (PDI) and the Oswestry Disability Questionnaire (ODQ) and their correlation with pain intensity in low back pain patients. Clin J Pain 1993; 9: 189–95.
38. Gronblad M, Jarvinen E, Airaksinen O, et al. Relationship of subjective disability with pain intensity, pain duration, pain location, and work-related factors in nonoperated patients with chronic low back pain. Clin J Pain 1996; 12: 194–200.
39. Rochmon DL, Ray SA, Kullch RJ, et al. Validity and utility of the Canadian occupational performance measure as an outcome measure in a craniofacial pain center. OTJR: Occupation, Participation and Health 2008; 28: 4–11.
40. Brown CS, Ling FW, Wan JY, et al. Efficacy of static magnetic field therapy in chronic pelvic pain: A double-blind pilot study. Am J Obstet Gynecol 2002; 187: 1581–7.
41. Nurmikko TJ, Serpell MG, Hoggart B, et al. Sativex successfully treats neuropathic pain characterised by allodynia: A randomised, double-blind, placebo-controlled clinical trial. Pain 2007; 133: 210–20.
42. Vranken JH, Dijkgraaf MGW, Kruis MR, et al. Iontophoretic administration of S(+)-ketamine in patients with intractable central pain: A placebo-controlled trial. Pain 2005; 118: 224–31.
43. Lurie Y, Brecker C, Daoud D, et al. Lamotrigine in the treatment of painful diabetic neuropathy: A randomized, placebo-controlled study. In Proceedings of the 9th World Congress on Pain. 16th edn, eds M. Devor, MC Rowbotham and Z. Wiesenfeld-Hallin. (Seattle: IASP Press, 2000), pp. 857–61.
44. Vranken JH, Dijkgraaf MGW, Kruis MR, et al. Pregabalin in patients with central neuropathic pain: A randomized, double-blind, placebo-controlled trial of a flexible-dose regimen. Pain 2008; 136: 150–7.
45. Hawk C, Long CR, Rowell RM, et al. A randomized trial investigating a chiropractic manual placebo: A novel design using standardized forces in the delivery of active and control treatments. J Altern Complement Med 2005; 11: 109–17.
46. Bergner M, Bobbitt RA, Kressel S, et al. The sickness impact profile: Conceptual formulation and methodology for the development of a health status measure. Int J Health Serv 1976; 6: 393–415.
47. Jensen MP, Turner JA, Romano JM, et al. Relationship of pain specific beliefs to chronic pain adjustment. Pain 1994; 57: 301–9.
48. Follick MJ, Smith TJ, Ahern DK. The sickness impact profile: A global measure of disability in chronic low bakc pain. Pain 1985; 21: 67–76.
49. Sullivan M, Ahlmen M, Bjelle A. Health status assessment in rheumatoid arthritis. I. Further work on the validity of the sickness impact profile. J Rheumatol 1990; 17: 439–47.
50. Romano JM, Turner JA, Jensen MP, et al. Chronic pain patient-spouse behavioral interactions predict patient disability. Pain 1995; 63: 353–60.
51. Epping-Jordan JE, Wahlgren DR, Williams RA, et al. Transition to chronic pain in men with low back pain: Predictive relationships among pain intensity, disability, and depressive symptoms. Health Psychol 1998; 17: 421–7.
52. Jensen MP, Turner MA, Romano JM. Correlates of improvement in multidisciplinary treatment of chronic pain. J Consult Clin Psychol 1994; 62: 172–9.
53. Burchiel KJ, Anderson VC, Brown FD, et al. Prospective, multicenter study of spinal cord stimulation for relief of chronic back and extremity pain. Spine 1996; 21: 2786–94.
54. Risch SV, Norvell NK, Pollock ML, et al. Lumbar strengthening in chronic low back pain patients. Physiologic and psychological benefits. Spine 1993; 18: 232–8.
55. Spincemaille GH, Klomp HM, Steyerberg EW, et al. Pain and quality of life in patients with critical limb ischaemia: Results of a randomized controlled multicentre study on the effect of spinal cord stimulation. Eur J Pain 2000; 4: 173–84.
56. Tak E, Staats P, Van HA, et al. The effects of an exercise program for older adults with osteoarthritis of the hip. J Rheumatol 2005; 32: 1106–13.
57. Moulin DE, Iezzi A, Amireh R, et al. Randomized trial of oral morphine for chronic non-cancer pain. Lancet 1996; 347: 143–7.
58. Carette S, Bell MJ, Reynolds WJ, et al. Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial [see comments]. Arthritis Rheum 1994; 37: 32–40.
59. Atkinson JH, Slater MA, Williams RA, et al. A placebo-controlled randomized clinical trial of nortriptyline for chronic low back pain. Pain 1998; 76: 287–96.
60. van Santen M, Bolwijn P, Verstappen F, et al. A randomized clinical trial comparing fitness and biofeedback training versus basic treatment in patients with fibromyalgia. J Rheumatol 2002; 29: 575–81.
61. Rudy TE. Multiaxial assessment of pain Multidimensional pain inventory Computer program user’s manual Version 2.1. (Pittsburgh: University of Pittsburgh School of Medicine, 1989), 1–72.
62. Riley JL, III, Zawacki TM, Robinson ME, et al. Empirical test of the factor structure of the West Haven-Yale Multidimensional Pain Inventory. Clin J Pain 1999; 15: 24–30.
63. Strong J, Westbury K, Smith G, et al. Treatment outcome in individuals with chronic pain: Is the Pain Stages of Change Questionnaire (PSOCQ) a useful tool? Pain 2002; 97: 65–73.
64. Deisinger JA, Cassisi JE, Lofland KR, et al. An examination of the psychometric structure of the Multidimensional Pain Inventory. J Clin Psychol 2001; 57: 765–83.
65. Bergstrom G, Jensen IB, Bodin L, et al. Reliability and factor structure of the Multidimensional Pain Inventory – Swedish Language Version (MPI-S). Pain 1998; 75: 101–10.
66. Lousberg R, Schmidt AJ, Groenman NH, et al. Validating the MPI-DLV using experience sampling data. J Behav Med 1997; 20: 195–206.
67. Olsson I, Bunketorp O, Carlsson SG, et al. Prediction of outcome in whiplash-associated disorders using West Haven-Yale Multidimensional Pain Inventory. Clin J Pain 2002; 18: 238–44.
68. Hooten WM, Townsend CO, Sletten CD, et al. Treatment outcomes after multidisciplinary pain rehabilitation with analgesic medication withdrawal for patients with fibromyalgia. Pain Med 2007; 8: 8–16.
69. Hooten WM, Townsend CO, Decker PA. Gender differences among patients with fibromyalgia undergoing multidisciplinary pain rehabilitation. Pain Med 2007; 8: 624–32.
70. Turk DC, Okifuji A, Sinclair JD, et al. Interdisciplinary treatment for fibromyalgia syndrome: Clinical and statistical significance. Arthritis Care Res 1998; 11: 186–95.
71. Nielson WR, Walker C, McCain GA. Cognitive behavioral treatment of fibromyalgia syndrome: Preliminary findings. J Rheumatol 1992; 19: 98–103.
72. Turk DC, Rudy TE, Kubinski JA, et al. Dysfunctional patients with temporomandibular disorders: Evaluating the efficacy of a tailored treatment protocol. J Consult Clin Psychol 1996; 64: 139–46.
73. Spence SH, Sharpe L, Newton-John T, et al. Effect of EMG biofeedback compared to applied relaxation training with chronic, upper extremity cumulative trauma disorders. Pain 1995; 63: 199–206.
74. Flor H, Birbaumer N. Comparison of the efficacy of electromyographic biofeedback, cognitive-behavioral therapy, and conservative medical interventions in the treatment of chronic musculoskeletal pain. J Consult Clin Psychol 1993; 61: 653–8.
75. Kjellby-Wendt G, Styf J, Carlsson SG. Early active rehabilitation after surgery for lumbar disc herniation: A prospective, randomized study of psychometric assessment in 50 patients. Acta Orthop Scand 2001; 72: 518–24.
76. Raja SN, Haythornthwaite JA, Pappagallo M, et al. Opioids versus antidepressants in postherpetic neuralgia: A randomized, placebo-controlled trial. Neurology 2002; 59: 1015–21.
77. Wallace MS, Magnuson S, Ridgeway B. Efficacy of oral mexiletine for neuropathic pain with allodynia: A double-blind, placebo-controlled, crossover study. Reg Anesth Pain Med 2000; 25: 459–67.
78. Martin DP, Sleyren CD, Williams BA, et al. Improvement in fibromyalgia symptoms with acupuncture: Results of a randomized controlled trial. Mayo Clin Proc 2006; 81: 749–57.
79. Harding VR, De CW, Richardson PH, et al. The development of a battery of measures for assessing physical functioning of chronic pain patients. Pain 1994; 58: 367–75.
80. Brooks D, Davis AM, Naglie G. Validity of 3 physical performance measures in inpatient geriatric rehabilitation. Arch Phys Med Rehabil 2006; 87: 105–10.
81. Maly MR, Costigan PA, Olney SJ. Determinants of self-report outcome measures in people with knee osteoarthritis. Arch Phys Med Rehabil 2006; 87: 96–104.
82. Walsh DA, Kelly SJ, Johnson PS, et al. Performance problems of patients with chronic low-back pain and the measurement of patient-centered outcome. Spine 2004; 29: 87–93.
83. Williams AC, Richardson PH, Nicholas MK, et al. Inpatient vs. outpatient pain management: Results of a randomised controlled trial. Pain 1996; 66: 13–22.
84. An B, Dai K, Zhu Z, et al. Baduanjin alleviates the symptoms of knee osteoarthritis. J Altern Complement Med 2008; 14: 167–74.
85. Pfingsten M, Leibing E, Harter W, et al. Fear-avoidance behavior and anticipation of pain in patients with chronic low back pain: A randomized controlled study. Pain Med 2001; 2: 259–66.
86. Weiner DK, Rudy TE, Glick RM, et al. Efficacy of percutaneous electrical nerve stimulation for the treatment of chronic low back pain in older adults. J Am Geriatr Soc 2003; 51: 599–608.
87. Frestedt J, Walsh M, Kuskowski M, et al. A natural mineral supplement provides relief from knee osteoarthritis symptoms: A randomized controlled pilot trial. Nutr J 2008; 7: 9.
90. Ng L, Chaudhary N, Sell P. The efficacy of corticosteroids in periradicular infiltration for chronic radicular pain: A randomized, double-blind, controlled trial. Spine 2005; 30: 857–62.
91. Smeets RJEM, Vlaeyen JWS, Hidding A, et al. Chronic low back pain: Physical training, graded activity with problem solving training, or both. The one-year post-treatment results of a randomized controlled trial. Pain 2008; 134: 263–76.
92. Haythornthwaite JA, Hegel MT, Kerns RD. Development of a sleep diary for chronic pain patients. J Pain Symptom Manage 1991; 6: 65–72.
93. Menefee LA, Frank ED, Doghramji K, et al. Self-reported sleep quality and quality of life for individuals with chronic pain conditions. Clin J Pain 2000; 16: 290–7.
94. Smith MT, Perlis ML, Smith MS, et al. Sleep quality and presleep arousal in chronic pain. J Behav Med 2000; 23: 1–13.
95. Rowbotham M, Harden N, Stacey B, et al. Gabapentin for the treatment of postherpetic neuralgia: A randomized controlled trial. JAMA 1998; 280: 1837–42.
96. Ahn SH, Park HW, Lee BS, et al. Gabapentin effect on neuropathic pain compared among patients with spinal cord injury and different durations of symptoms. Spine 2003; 28: 341–6.
97. Watson CP, Vernich L, Chipman M, et al. Nortriptyline versus amitriptyline in postherpetic neuralgia: A randomized trial. Neurology 1998; 51: 1166–71.
98. Bone M, Critchley P, Buggy DJ. Gabapentin in postamputation phantom limb pain: A randomized, double-blind, placebo-controlled, cross-over study. Reg Anesth Pain Med 2002; 27: 481–6.
99. Finnerup NB, Sindrup SH, Bach FW, et al. Lamotrigine in spinal cord injury pain: A randomized controlled trial. Pain 2002; 96: 375–83.
100. Tolle T, Freynhagen R, Versavel M, et al. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: A randomized, double-blind study. Eur J Pain 2008; 12: 203–13.
101. Bone M, Critchley P, Buggy DJ. Gabapentin in postamputation phantom limb pain: A randomized, double-blind, placebo-controlled, cross-over study. Reg Anesth Pain Med 2002; 27: 481–6.
102. Fishbain DA, Hall J, Meyers AL, et al. Does pain mediate the pain interference with sleep problem in chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine. J Pain Symptom Manage 2008; 36: 639–47.
103. Kosinski M, Janagap CC, Gajria K, Schein J Psychometric testing and validation of the Chronic Pain Sleep Inventory. Clin Ther 2007; 29 (Suppl 1): 2562–77.
104. Florete OG, Xiang J, Vorsanger GJ. Effects of extended-release tramadol on pain-related sleep parameters in patients with osteoarthritis. Expert Opin Pharmacother 2008; 9: 1817–27.
105. Kivitz A, Ma C, Ahdieh H, et al. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee. Clin Ther 2006; 28: 352–64.
106. Harati Y, Gooch C, Swenson M, et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998; 50: 1842–6.
107. Arnold LM, Russell IJ, Diri EW, et al. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. J Pain 2008; 9: 792–805.
108. Currie SR, Wilson KG, Pontefract AJ, et al. Cognitive-behavioral treatment of insomnia secondary to chronic pain. J Consult Clin Psychol 2000; 68: 407–16.
109. Tugwell P, Boers M, Brooks P, et al. OMERACT: An international initiative to improve outcome measurement in rheumatology. Trials 2007; 8: 38.
110. Dworkin RH, Turk DC, Wyrwich KW, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT Recommendations. J Pain 2008; 9: 105–21.
111. Rose M, Bjorner JB, Becker J, et al. Evaluation of a preliminary physical function item bank supported the expected advantages of the Patient-Reported Outcomes Measurement Information System (PROMIS). J Clin Epidemiol 2008; 61: 17–33.
112. Smith MT, Haythornthwaite JA. How do sleep disturbance and chronic pain inter-relate? Insights from the longitudinal and cognitive-behavioral clinical trials literature. Sleep Med Rev 2004; 8: 119–32.
113. Buysse DJ, Reynolds CF, III, Monk TH, et al. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res 1989; 28: 193–213.
114. Edinger JD, Wohlgemuth WK, Krystal AD, et al. Behavioral insomnia therapy for fibromyalgia patients: A randomized clinical trial. Arch Intern Med 2005; 165: 2527–35.

References

1. Dersh J, Gatchel RJ, Polatin P. Chronic spinal disorders and psychopathology. Research findings and theoretical considerations. Spine J 2001; 1: 88–94.
2. Wolff B, Burns JW, Quartana PJ, et al. Pain catastrophizing, physiological indexes, and chronic pain severity: Tests of mediation and moderation models J Behav Med 2007; 31: 105–14.
3. Von Korff M, Crane P, Lane M, et al. Chronic spinal pain and physical-mental comorbidity in the United States: Results from the national comorbidity survey replication. Pain 2005; 113: 331–9.
4. Stang PE, Brandenburg NA, Lane MC, et al. Mental and physical comorbid conditions and days in role among persons with arthritis. Psychosom Med 2006; 68: 152–8.
5. Sullivan M, Edlund MJ, Zhang L, Unutzer J, Wells KB. Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Inter Med 2006; 166: 2087–93.
6. Breckenridge J, Clark JD. Patient characteristics associated with opioid versus nonsteroidal anti-inflammatory drug management of chronic low back pain. J Pain 2003; 4: 344–50.
7. Wilsey BL, Fishman SM, Tsodikov A, et al. Psychological comorbidities predicting prescription opioid abuse among patients in chronic pain presenting to the emergency department. Pain Med 2008; 9: 1107–17.
8. Rosenblum A, Joseph H, Fong C, et al. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA 2003; 289: 2370–78.
9. Doverty M, White JM, Somogyi AA, et al. Hyperalgesic responses in methadone maintenance patients. Pain 2001; 90: 91–6.
10. Chang G, Chen L, Mao J. Opioid tolerance and hyperalgesia. Med Clin North Amer 2007; 91: 199–211.
11. White JM. Pleasure into pain: The consequences of long-term opioid use. Addict Behav 2004; 29, 1311–24.
12. Vanderah TW, Suenaga NM, Ossipov MH, et al. Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance. J Neurosc 2001; 21: 279–86.
13. Xie JY, Herman DS, Stiller CO, et al. Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance. J Neurosci 2005; 25: 409–16.
14. King T, Gardell LR, Wang R, et al. Role of NK-1 transmission in opioid-induced hyperalgesia. Pain 2005; 116: 276–88.
15. Watkins LR, Hutchinson MR, Ledeboer A, et al. Norman Cousins Lecture Glia as the “bad guys”: implications for improving clinical pain control and the clinical utility of opioids. Brain Behav Immun 2007; 21: 131–46.
16. Streltzer J, Johansen L. Prescription drug dependence and evolving beliefs about pain management. Am J Psychiatry 2006; 163: 5948.
17. Wu S M, Compton P, Bolus R, et al. The addiction behaviors checklist: Validation of a new clinician-based measure of inappropriate opioid use in chronic pain. J Pain Symptom Manage 2006; 32: 342–51.
18. Ives TJ, Chelminski PR, Hammett-Stabler CA, et al. Predictors of opioid misuse in patients with chronic pain: A prospective cohort study. BMC Health Services Research 2006; 6: 46.
19. Miller NS, Swiney T, Barkin RL. Effects of opioid prescription medication dependence and detoxification on pain perceptions and self-reports. Am J Ther 2006; 13: 436–44.
20. Martell BA, O’Connor PG, Kerns RD, et al. Systematic review: Opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med 2007; 146: 116–27.
21. McWilliams LA, Goodwin RD, Cox BJ. Depression and anxiety associated with three pain conditions: Results from a nationally representative sample. Pain 2004; 111: 77–83.
22. Ciccone DS, Just N, Bandilla EB, et al. Psychological correlates of opioid use in patients with chronic nonmalignant pain: A preliminary test of the downhill spiral hypothesis. J Pain Symptom Manage 2000; 20: 180–92.
23. Eriksen J, Sjøgren P, Bruera E, Ekholm O, Rasmussen NK. Critical issues on opioids in chronic non-cancer pain: An epidemiological study. Pain 2006; 125: 172–9.
24. Edlund MJ, Steffick D, Hudson T, Harris KM, Sullivan M. Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain 2007; 129: 355–62.
25. Waddell G, McCulloch JA, Kummel E, Venner RM. Nonorganic physical signs in low back pain. Spine 1980; 5: 117–25.
26. Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: A literature review. Arch Inter Med 2003; 163: 2433–45.
27. Lydiard RB. Irritable bowel syndrome, anxiety, and depression: What are the links? J Clin Psychiatry 2001; 62 Suppl 8: 38–45.
28. Meeks TW, Dunn LB, Kim DS, et al. Chronic pain and depression among geriatric psychiatry inpatients. Am J Ther 2007; 23: 637–42.
29. Roy-Byrne PP, Davidson KW, Kessler RC, et al. Anxiety disorders and comorbid medical illness. Gen Hosp Psychiatry 2008; 30: 208–25.
30. Gureje O, Von Korff M, Kola L, et al. The relation between multiple pains and mental disorders: Results from the World Mental Health Surveys. Pain 2008 135: 82–91.
31. Katerndahl D. Panic plaques: Panic disorder coronary artery disease in patients with chest pain. J Am Board Fam Pract 2004; 17: 114–26.
32. Huffman JC, Pollack MH. Predicting panic disorder among patients with chest pain: An analysis of the literature. Psychosomatics 2003; 44: 222–36.
33. Schmidt NB, Santiago HT, Trakowski JH, Kendren JM. Pain in patients with panic disorder: Relation to symptoms, cognitive characteristics and treatment outcome. Pain Res Manage 2002; 7: 134–41.
34. Asmundson GJ, Coons MJ, Taylor S, Katz J. PTSD and the experience of pain: Research and clinical implications of shared vulnerability and mutual maintenance models. Can J Psychiatry 2002; 47: 930–7.
35. Stam R. PTSD and stress sensitisation: A tale of brain and body Part 2: Animal models. Neurosci Biobehav Rev 2007; 31: 558–84.
36. Stam R. PTSD and stress sensitisation: A tale of brain and body Part I: Human studies. Neurosci Biobehav Rev 2007; 31: 530–57.
37. Kirmayer LJ, Sartorius N. Cultural models and somatic syndromes. Psychosom Med 2007; 69: 832–40.
38. Fishbain D. Where have two DSM revisions taken us for the diagnosis of pain disorder in chronic pain patients? Amer J Psychiatry 1996; 153: 137–8.
39. Anooshian J, Streltzer J, Goebert D. Effectiveness of a psychiatric pain clinic. Psychosomatics 1999; 40: 226–32.
40. Fröhlich C, Jacobi F, Wittchen H. DSM-IV pain disorder in the general population. Eur Arch Psychiatry Clin Neurosci 2006; 256: 187–96.
41. Lieb R, Meinlschmidt G, Araya R. Epidemiology of the association between somatoform disorders and anxiety and depressive disorders: An update. Psychosom Med 2007; 69: 860–3.
42. Streltzer J, Eliashof BA, Kline AE Goebert D. Chronic pain disorder following physical injury. Psychosomatics 2000; 41: 227–34.
43. Zimmerman M. Diagnosing personality disorders. Arch Gen Psychiatry 1994; 51: 225–45.
44. Reich J, Tupin JP, Abramowitz SL. Psychiatric diagnosis of chronic pain patients. Am J Psychiatry 1983; 140: 1495–98.
45. Conrad R, Schilling G, Bausch C, et al. Temperament and character personality profiles and personality disorders in chronic pain patients. Pain 2007; 133: 197–209.
46. Waddell G, Newton M, Henderson I, Sommerville D, Main C. A Fear-avoidance Beliefs Questionnaire (FABQ) and the role of fear-avoidance beliefs in chronic low back pain and disability. Pain 1993: 52: 157–68.
47. Schmahl C, Greffrath W, Baumgärtner U, et al. Differential nociceptive deficits in patients with borderline personality disorder and self-injurious behavior: laser-evoked potentials, spatial discrimination of noxious stimuli, and pain ratings. Pain 2004; 110: 470–9.
48. Reeves RR, Torres RA. Exacerbation of psychosis by misinterpretation of physical symptoms. South Med J 2003; 96: 702–4.
49. Singh MK, Giles LL, Nasrallah HA. Pain insensitivity in schizophrenia: Trait or state marker? J Psychiatr Pract 2006; 12: 90–102.
50. Hooley JM, Delgado ML. Pain insensitivity in the relatives of schizophrenia patients. Schizophr Res 2001; 47: 265–73.
51. Kunz M, Scharmann S, Hemmeter U, Schepelmann K, Lautenbacher S. The facial expression of pain in patients with dementia. Pain 2007; 133: 221–8.

References

1. Turk DC. Efficacy of multidisciplinary pain centers in the treatment of chronic pain. In Pain Treatment Centers at a Crossroads: A practical and conceptual reappraisal, eds. MJM Mitchell and JN Campbell. (Seattle, WA: IASP Press, 1996).
2. Turk DC. Clinical effectiveness and cost-effectiveness of treatments for patients with chronic pain. Clin J Pain 2002; 18: 355–65.
3. Flor H, Birbaumer N, Turk DC. The psychobiology of chronic pain. Adv Behav Res Ther 1990; 12: 47–84.
4. Atkinson JH, Slater MA, Patterson TL, Grant I, Garfin SR Prevalence, onset, and risk of psychiatric disorders in chronic pain patients: A controlled study. Pain 1991; 45: 111–21.
5. Banks SM, Kerns RD. Explaining high rates of depression in chronic pain: A diathesis-stress framework. Psychol Bull 1996; 119: 95–110.
6. Holroyd KA, Malinoski P, Davis, MK, Lipchik JL. The three dimensions of headache impact: Pain, disability, and affective distress. Pain 1999; 83: 571–8.
7. Jamison RN, Rudy TE, Penzein DB, Mosley TH. Cognitive-behavioral classifications of chronic pain: Replication and extension of empirically derived patient profiles. Pain 1994; 57: 277–92.
8. Klapow JC, Slater MA, Patterson TL, Atkinson JH, Weickgenant AL, Grant I, Garfin SR. Psychosocial factors discriminate multidimensional clinical groups of chronic low back pain patients. Pain 1995; 62; 349–55.
9. Robinson ME, Riley III, JL. The role of emotion in pain. In Psychosocial Factors in Pain: Critical perspectives, eds RJ Gatchell and DC Turk. (New York: Guilford Press, 1999).
10. Fernandez E, Kerns RD. Anxiety, Depression, and Anger: Core components of negative affect in medical populations. In The SAGE Handbook of Personality Theory and Assessment: Personality Theories and Models (Vol 1), eds. GJ Boyle, G Matthews and DH Saklofske. (Trowbridge: Cromwell Press Ltd, 2008).
11. Chaves J, Barber TX. Hypnotism and surgical pain. In Behavior Control and Modification of Psychological Activity, ed. DI Mostovsky. (Englewood Cliffs: Prentice Hall, 1976).
12. Mersky, H. Pain and personality. In The Psychology of Pain, ed. R. Sternbach. (New York: Raven Press, 1978).
13. Asmundson GJ, Jacobson SJ, Allerdings MD, Norton GR. Social phobia in disabled workers with chronic musculoskeletal pain. Behav Res Ther 1996; 34: 939–43.
14. Beitman BD, Mukerji V, Kushner M, et al. Validating studies for panic disorder in patients with angiographically normal coronary arteries. Med Clin North Amer 1991; 75: 1143–55.
15. Beckham JC, Crawford AL, Feldman ME, et al. Chronic posttraumatic stress disorder and chronic pain in Vietnam combat veterans. J Psychosom Res 1997; 43: 379–89.
16. Kulich RJ, Mencher P, Bertrand C, Maciewicz R. Comorbidity of post-traumatic stress disorder and pain: Implications for clinical and forensic assessment. Curr Rev Pain 2000; 4: 36–48.
17. Fernandez, E. Anxiety, Depression, and Anger in Pain. (Dallas, TX: Advanced Psychological Resources, Inc, 2002).
18. Asmundson GJ, Jacobson SJ, Allerdings, MD. Fear and avoidance in dysfunctional chronic back pain patients. Pain 1997; 69, 231–6.
19. Lethem J, Slade, PO, Troup, JPG, Bentley G. Outline of a fear-avoidance model of exaggerated pain perception. Behav Res Ther 1983; 21: 401–8.
20. Romano JM, Turner JA. Chronic pain and depression: Does the evidence support a relationship? Psychol Bull 1985; 97: 18–34.
21. Haythornthwaite JA, Sieber WJ, Kerns RD. Depression and the chronic pain experience. Pain 1991; 46: 177–84.
22. Summers JD, Rapoff, MA, Varghese G, Porter K, Palmer RE. Psychosocial factors in chronic spinal cord injury pain. Pain 1991; 47: 183–9.
23. Feeney SL. The relationship between pain and negative affect in older adults: Anxiety as a predictor of pain. J Anx Disord 2004; 18: 733–44.
24. Fernandez E, Turk DC. The scope and significance of anger in the experience of chronic pain. Pain 1995; 61: 165–75.
25. Beutler LE, Engle D, Oro-Beutler, ME, Daldrup R. Inability to express intense negative affect: A common link between depression and pain? J Consult Clin Psychol 1986; 54: 752–9.
26. Catchlove RFH, Braha RED. A test to measure the awareness and expression of anger. Psychother Psychosom 1985; 43: 113–9.
27. Kerns RD, Rosenberg R, Jacob, MC. Anger expression and chronic pain. J Behav Med 1994; 17: 57–67.
28. Spielberger CD, Gorsuch RL, Lushene R. Manual for the State-Trait Anxiety Inventory (Palo Alto, CA: Consulting Psychologists Press, 1970).
29. McNair DM, Lorr M, Doppleman LF. Profile of Mood States. (San Diego, CA: Educational and Industrial Testing Service, 1971).
30. Beck AT, Ward CH, Mendelsohn M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561–71.
31. Radloff LS. The CES-D Scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385–401.
32. Sullivan MD. Assessment of psychiatric disorders. In Handbook of Pain Assessment, 2nd edn., eds. DC Turk and R Melzack. (New York: Guilford Press, 2001).
33. Brown GK. A causal analysis of chronic pain and depression. J Abnorm Psychol 1990; 99: 127–37.
34. Katon W, Egan K, Miller D. Chronic pain: Lifetime psychiatric diagnosis and family history. Am J Psychiatry 1985; 142: 1156–60.
35. Von Korff M, Simon G. The relationship between pain and depression. Br J Psych 1996; 168(Supplement 30): 101–8.
36. Geisser ME, Roth RS, Robinson ME. Assessing depression among persons with chronic pain using the Center for Epidemiological Studies – Depression Scale and the Beck Depression Inventory: A comparative analysis. Clin J Pain 1997; 13: 163–70.
37. Rodin G, Voshart K. Depression in the medically ill: An overview. Am J Psychiatry 1986; 143: 696–705.
38. Koenig HG, George LK, Peterson, BL, Pieper CF. Depression in medically ill hospitalized older adults: Prevalence, characteristics, and course of symptoms according to six diagnostic schemes. Am J Psychiatry 1997; 164: 1376–83.
39. McCracken, LM, Faber SD, Janeck AS. Pain-related anxiety predicts nonspecific physical complaints in persons with chronic pain. Behav Res Ther 1998; 34: 927–33.
40. Kori SH, Miller RP, Todd DD. Kinesiophobia: A new view of chronic pain behavior. Pain Manage, January/February, 35–43.
41. Vlaeyen JW, de Jong J, Geilen M, Heuts PH, van Breukelen G. Graded exposure in vivi in the treatment of pain-related fear: A replicated single-case experimental design in four patients with chronic low back pain. Behav Res Ther 2001; 39: 151–66.
42. McCracken LM, Zayfert C, Gross RT. The Pain Anxiety Symptoms Scale: Development and validation of a scale to measure fear of pain. Pain 1992; 50: 67–73.
43. Waddell G, Newton M, Henderson I, Somerville D, Main C. A Fear-Avoidance Beliefs Questionnaire (FABQ) and the role of fear-avoidance beliefs in chronic low back pain and disability. Pain 1993; 52: 157–68.
44. McNeil DW, Rainwater III AJ. Development of the Fear of Pain Questionnaire – III. J Behav Med 1998; 21: 389–410.
45. Polatin PB, Kinney RK, Gatchel RJ, Lillo E, Mayer TG. Psychiatric illness and chronic low-back pain. The mind and the spine – which goes first? Spine 1993; 18: 66–71.
46. Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA. Manual for the State-Trait Anxiety Inventory (Form Y) (Palo Alto: Consulting Psychologists Press, 1983).
47. Mongini F, Defilippi N, Negro C. Chronic daily headache. A clinical and psychological profile before and after treatment. Headache 1997; 37: 83–7.
48. McCracken LM, Faber SD, Janeck AS. Pain-related anxiety predicts nonspecific physical complaints in persons with chronic pain. Behav Res Ther 1998; 36: 621–30.
49. McCracken LM, Gross RT, Aikens J, Carnrike CLM. The assessment of anxiety and fear in persons with chronic pain: A comparison of instruments. Behav Res Ther 1996; 34: 927–33.
50. Crombez G, Vlaeyen JWS, Heuts PHTG, Lysens R. Pain-related fear is more disabling than pain itself: Evidence on the role of pain-related fear in chronic back pain disability. Pain 1999; 80: 329–39.
51. Larsen DK, Taylor S, Asmundson GJG. Exploratory factor analysis of the Pain Anxiety Symptoms Scale in patients with chronic pain complaints. Pain 1997; 69: 27–34.
52. Vlaeyen JW, Seelen HA, Peters M, et al. Fear of movement/(re)injury and muscular reactivity in chronic low back pain patients: An experimental investigation. Pain 1999; 82: 297–304.
53. Pfingsten M, Kroner-Herwig B, Leibing E, Kronshage U, Hildebrandt J. Validation of a German version of the Fear Avoidance Beliefs Questionnaire (FABQ). Eur J Pain 2000; 4: 259–66.
54. Pfingsten M, Leibing E, Harter W, et al. Fear-avoidance behavior and anticipation of pain in patients with chronic low back pain: A randomized controlled study. Pain Med 2001; 2: 259–66.
55. Buer N, Linton SJ. Fear-avoidance beliefs and catastrophizing: Occurrence and risk factor in back pain and ADL in the general population. Pain 2002; 99: 485–91.
56. Klenerman L, Slade PD, Stanley IM. The prediction of chronicity in patients with an acute attack of low back pain in a general medical practice. Spine 1995; 20: 478–84.
57. Beck AT, Steer RA. Beck Depression Inventory (San Antonio, TX: Psychological Corporation, 1983).
58. Yonkers, KA, Samson J. Mood disorders measures. In American Psychiatric Association: Handbook of Psychiatric Measures. (Washington, DC: American Psychiatric Association, 2000).
59. Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clin Psychol Rev 1988; 8: 77–100.
60. Beck AT, Steer RA, Brown GK. Beck Depression Inventory-Second Edition Manual (San Antonio, TX: Psychological Corporation, Harcourt Brace, 1986).
61. Moran PW, Lambert MJ. A review of current assessment tools for monitoring changes in depression. In The Assessment of Psychotherapy and Outcomes, eds. MD Lamber, ER Christiensen and SS Dejolie. (New York: Wiley, 1983).
62. Applebaum KA, Blanchard EB, Hickling EJ, Alfonso M, et al. Cognitive-behavioral treatment of a veteran population with moderate to severe rheumatoid arthritis. Behav Ther 1988; 19: 489–502.
63. Burns JW, Johnson BJ, Mahoney N, Devine J, Pawl R. Cognitive and physical capacity process variables predict long-term outcome after treatment for chronic pain. J Consult Clin Psychol 1998; 66: 434–9.
64. Kerns RD, Turk DC, Holzman AD, Rudy TE. Comparison of cognitive-behavioral and behavioral approaches to the outpatient treatment of chronic pain. Clin J Pain 1986; 1: 195–203.
65. Khatami M, Rush AJ. A one-year follow-up of the multimodal treatment for chronic pain. Pain 1982 14: 45–52.
66. Kleinke CL. How chronic pain patients cope with pain: Relation to treatment outcome in a multidisciplinary pain clinic. Cognit Ther Res 1992; 16: 669–85.
67. Marhold C, Linton SJ, Melin L. A cognitive-behavioral return-to-work program: Effects on pain patients with a history of long-term versus short-term sick leave. Pain 2001; 91: 155–63.
68. Radloff LS, Locke BZ. Center for Epidemiologic Studies Depression Scale (CES-D). In Handbook of Psychiatric Measures. (Washington, DC: American Psychiatric Association, 2000).
69. Roberts RE. Reliability of the CES-D in different ethnic contexts. Psychiatry Res 1980; 2: 125–34.
70. Naughton MJ, Wiklund I. A critical review of dimension-specific measures of health-related quality of life in cross-cultural research. Qual Life Res 1993; 2: 397–432.
71. Arnstein P, Caudill M, Mandle CL, Norris A, Beasley R. Self efficacy as a mediator of the relationship between pain intensity, disability, and depression in chronic pain patients. Pain 1999; 80: 483–91.
72. Fechner-Bates S, Coyne JC, Schwenk TL. The relationship of self-reported distress to depressive disorders and other psychopathology. J Consul Clin Psychol 1994; 62: 550–9.
73. Weissman MM, Sholomskas D, Portenger M, et al. Assessing depressive symptoms in five psychiatric populations: A validation study. Am J Epidemiol 1977; 106: 203–14.
74. Blalock, SJ, DeVellis RF, Brown GK, Wallston KA. Validity of the Center for Epidemiological Studies Depression Scale in arthritis populations. Arthritis Rheum 1989; 32: 991–7.
75. Magni G, Caldieron C, Rigatti-Luchini S, Merskey H. Chronic musculoskeletal pain and depressive symptoms in the general population: An analysis of the 1st National Health and Nutrition Examination Survey data. Pain 1990; 43: 299–307.
76. Turk DC, Okifuji A. Detecting depression in chronic pain patients: Adequacy of self-reports. Behav Res Ther 1994; 32: 9–16.
77. Nielsen WR, Walker C, McCain GA. Cognitive-behavioral treatment of fibromyalgia: Preliminary findings. J Rheumatol 1992; 19: 98–103.
78. Turner JA, Clancy S, McQuade KJ, Cardenas DD. Effectiveness of behavioral therapy for chronic low back pain: A component analysis. J Consult Clin Psychol 1990; 58: 573–9.
79. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56–62.
80. Zitman FG, Mennen MFG, Griez E, et al. The different versions of the Hamilton Depression Rating Scale. In The Hamilton Scales (Psychopharmacology Series 9), eds. P Bech and A Coppen. (Berlin: Springer-Verlag, 1990).
81. Carroll BJ, Feinburg M, Smouse PE, et al. The Carroll Rating Scale for Depression: Development, reliability, and validation. Br J Psychiatry 1981; 138: 194–200.
82. Potts MK, Daniels M, Burnam A, et al. A structured interview version of the Hamilton Depression Rating Scale: Evidence of reliability and versatility of administration. J Psychiatr Res 1990; 24: 335–50.
83. Reynolds WM., Kobak KA. Reliability and validity of the Hamilton Depression Inventory: A paper and pencil version of the Hamilton Rating Scale Clinical Interview. Psychol Assess 1990; 7: 472–83.
84. Kobak KA, Reynolds WM, Rosenfeld R, et al. Development and validation of a computer-administered version of the Hamilton Depression Rating Scale. Psychol Assess 1990; 2: 56–63.
85. Gastpar, M, Gilsdorf, U. The Hamilton Depression Rating Scale in a WHO collaborative program. In The Hamilton Scales (Psychopharmacology Series 9), eds. P Bech and A Coppen (Berlin: Springer-Verlag, 1990).
86. Maier W, Phillip M, Heuser I, et al. Improving depression severity assessment, I: Content, concurrent, and external validity of three observer scales. J Psychiatr Res 1988; 22: 3–12.
87. Rehm L, O ’ Hara M. Item characteristics of the Hamilton Rating Scale for Depression. J Psychiatr Res 1985; 19: 31–41.
88. Zung WWK. A self-rating depression scale. Arch Gen Psychiatry 1965; 12: 63–5.
89. Biggs JT, Wylie LT, Ziegler VE. Validity of the Zung Self-Rating Depression Scale. Br J Psychiatry 1978; 132: 381–5.
90. Guy W. ECDEU Assessment Manual of Psychopharmacology-Revised (DHEW Publ No ADM 76–338). Rockville, MD: US Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs. (1976).
91. Yesavage JA, Brink TL. Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res 1983; 17: 37–49.
92. Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. Clin Gerontol 1986; 5: 165–73.
93. Jamison C, Scogin F. Development of an interview based geriatric depression rating scale. Int J Aging Hum Dev 1992; 35: 193–204.
94. Burke WJ, Roccaforte WH, Wengel SP, et al. The reliability and validity of the Geriatric Depression Rating Scale administered by telephone. J AmGeriatr Soc 1995; 43: 674–9.
95. Brink TA, Yesavage JA, Lum O, et al. Screening tests for geriatric depression. Clin Gerontol 1982; 1: 37–43.
96. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361–70.
97. Snaith RP, Zigmond AS. The Hospital Anxiety and Depression Scale Manual (Windsor: Nfer-Nelson, 1994)
98. Moorey S, Greer S, Watson M, et al. The factor structure and factor stability of the Hospital Anxiety and Depression Scale in patients with cancer. Br J Psychiatry 1991; 158: 255–9.
99. Kerns RD, Turk DC, Rudy TE. The West Haven-Yale Multidimensional Pain Inventory (WHYMPI). Pain 1985; 23: 345–56.
100. McCarberg B, Wolf J. Chronic pain management in a health maintenance organization. Clin J Pain 1999; 15: 50–7.
101. Buss AH, Durkee A. An inventory for assessing different kinds of hostility. J Consult Psychol 1957; 21: 343–9.
102. Megargee EI, Cook PE, Mendelsohn GA. Development and validation of an MMPI scale of assaultiveness in overcontrolled individuals. J Abnorm Psychol 1967; 72: 519–28.
103. Caine TM, Foulds GA, Hope K. Manual of the Hostility and Direction of Hostility Questionnaire (London: University of London, 1967).
104. Cook W, Medley D. Proposed hostility and pharisaic-virtue scales for the MMPI. J Appl Psychol 1954; 38: 414–18.
105. Zelin ML, Adler G, Myerson PG. Anger self-report: An objective questionnaire for the measurement of aggression. J Consult Clin Psychol 1972; 39: 340.
106. Evans DR, Strangeland M. Development of the Reaction Inventory to measure anger. Psychol Rep 1971; 29: 412–14.
107. Novaco RW. The effect of disposition of anger and degree of provocation on self-report and physiological measures of anger in various modes of provocation. Unpublished manuscript, Indiana University, Bloomington, IN. (1974)
108. Siegel JM. The Multidimensional Anger Inventory. J Pers Soc Psychol 1986; 51: 191–200.
109. Fernandez E. The Targets and Reasons for Anger in Pain Sufferers: A structured interview. Unpublished manuscript, Southern Methodist University. (1996).
110. Spielberger CD. State-Trait Anger Expression Inventory Professional Manual (Odessa, FL: Psychological Assessment, 1988).
111. Spielberger CD. The State-Trait Anger Expression Inventory-2 Professional Manual (Odessa, FL: Psychological Assessment, 1999).
112. Hathaway SR, McKinley J. The Minnesota Multiphasic Personality Inventory (Minneapolis: University of Minnesota Press, 1943).
113. Hathaway SR, McKinley JC, Butcher JN, et al. Minnesota Multiphasic Personality Inventory-2: Manual for administration (Minneapolis: University of Minnesota Press, 1989).
114. Bradley LA, McKendree-Smith NL. Assessment of psychological status using interviews and self-report instruments. In Handbook of Pain Assessment, 2nd edn., eds. DC Turk and R Melzack. (New York: Guilford Press, 2001).
115. Pincus T, Callahan LF, Bradley LA, Vaughn WK, Wolfe F. Elevated MMPI scores for hypochondriasis, depression, and hysteria in patients with rheumatoid arthritis reflect disease rather than psychological status. Arthritis Rheum 1986; 29: 1456–66.
116. Guck TP, Meilman PW, Skultety M, Poloni ID. Pain-patient Minnesota Multiphasic Personality Inventory subgroups: Evaluation of long-term treatment outcome. J Behav Med 1988; 11: 159–69.
117. McCreary C. Empirically derived MMPI profile clusters and characteristics of low back pain patients. J Consult Clin Psychol 1985; 53: 558–60.
118. Moore JE, Armentrout DP, Parker JC, Kivlahan DR. Empirically-derived pain-patient MMPI subgroups: Prediction of treatment outcome. J Behav Med 1986; 9: 51–63.
119. Clark ME. MMPI-2 Negative Treatment Indicators Content and Content Component Scales: Clinical correlates and outcome prediction for men with chronic pain. Psychol Assess 1996; 8: 32–8.
120. Vendrig AA, Derksen JL, deMey HR. Utility of selected MMPI-2 scales in the outcome prediction for patients with chronic back pain. Psychol Assess 1999; 11: 381–5.
121. Derogatis L. The SCL-90R Manual – II: Administration, scoring and procedures (Towson, MD: Clinical Psychometric Research, 1983).
122. Preveler RC, Fairburn CG. Measurement of neurotic symptoms by self-report questionnaire: Validity of the SCL-90-R. Psychol Med 1990; 20: 873–9.
123. Jamison RN, Rock DL, Parris WCV. Empirically derived Symptom Checklist 90 subgroups of chronic pain patients: A cluster analysis. J Behav Med 1988; 11: 147–58.
124. Derogatis L, Spencer P. BSI Manual I: Administration and procedures (Baltimore, MD: Johns Hopkins University, Clinical Psychometric Unit, 1983).
125. Millon T, Green C, Meagher R. Millon Behavioral Health Inventory manual 3rd edn. (Minneapolis, MN: National Computer Systems, 1983).
126. Gatchell RJ, Mayer TG, Capra P, Barnett J, Daimond P. Millon Behavioral Health Inventory: Its utility in predicting physical function in patients with low back pain. Arch Phys Med Rehabil 1986; 67: 878–82.
127. Sweet JJ, Breuer SR, Hazlewood LA, Toye R, Pawl RP. The Millon Behavioral Health Inventory: Concurrent and predictive validity in a pain treatment center. J Behav Med 1985; 8: 215–26.
128. Pilowsky I, Spence ND. Patterns of illness behavior in patients with intractable pain. J Psychosom Res 1975; 19: 279–87.
129. Pilowsky I, Spence ND. Manual for the Illness Behavior Questionnaire (IBQ). Unpublished manual (available from the authors) (1994).
130. Dworkin RH, Cooper EM, Siegfried RN. Chronic pain and disease conviction. Clin J Pain 1996; 12: 111–7.
131. Keefe FJ, Crisson JE, Maltbie A, Bradley LA, Gil KM. Illness behavior as a predictor of pain and overt behavior patterns in chronic low back pain patients. J Psychosom Res 1986; 30: 543–51.
132. Waddell G, Pilowsky I, Bond MR. Clinical assessment and interpretation of abnormal illness behavior in low back pain. Pain 1989; 39: 41–53.
133. Ware JE, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36), I: Conceptual framework and item selection. Med Care 1992; 30: 473–83.
134. Kazis LE, Skinner K, Rogers W, et al. Health status and outcomes of veterans: physical and mental component summary scores (sf-36v). 1998 national survey of ambulatory care patients. Mid-year executive report. Office of Performance and Quality, Health Assessment Project, Center for Health Quality Outcomes and Economic Research, HSRD Service, Veterans Administration, Washington, D.C. and Bedford (MA), (1998).
135. Ware JE, Bayliss MS, Rogers WH, Kosinski M, Tarlov AR. Differences in 4-year health outcomes for elderly and poor, chronically ill patients treated in HMO and fee-for-service systems. JAMA 1996; 276: 1039–47.
136. Ware JE, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A users manual (Boston, MA: Health Assessment Lab, New England Medical Center, 1994).
137. McHorney CA, Ware JE, Lu JFR, et al. The MOS 36-item Short-Form Health Survey (SF-36), III: Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994; 32, 40–66.
138. Backonja M, Beydoun A, Edwards KR, et al. for the Gabapentin Diabetic Neuropathy Study Group. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. JAMA 1998; 280: 1831–6.
139. Katz JN, Harris TM, Larson MG, et al. Predictors of functional outcomes after arthroscopic partial meniscectomy. J Rheumatol 1992; 19, 1938–42.
140. Rogers WH, Wittink H, Wagner A, Cynn D, Carr DB. Assessing individual outcomes during outpatient multidisciplinary chronic pain treatment by means of an augmented SF-36. Pain Med 2000; 1: 44–54.
141. McHorney C, Tarlov A. Individual-patient monitoring in clinical practice: Are available health status surveys adequate. Qual Life Res 1995; 4: 293–307.
142. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. for the Gabapentin Postherpetic Neuralgia Study Group. Gabapentin for the Treatment of Postherpetic Neuralgia A Randomized Controlled Trial. JAMA 1998; 280: 1837–42.
143. Helzer JE, Robins LN. The Diagnostic Interview Schedule: Its development, evaluation and use. Soc Psychiatry Psychiatr Epidemiol 1988; 23: 6–16.
144. Robins LN, Helzer JE, Croughan J, Ratcliff KS. National Institute of Mental Health Diagnostic Interview Schedule. Arch Gen Psychiatry 1981; 38, 381–9.
145. Spitzer RL, Williams JBW, Gibbon M, First MB. Structured Clinical Interview for DSM-III-R (Washington, DC: American Psychiatric Press, 1990).
146. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edn. (Washington, DC: American Psychiatric Association, 1994).
147. Helzer JE, Spitznagel EL, McEvoy L. The predictive validity of lay Diagnostic Interview Schedule diagnoses in the general population: A comparison with physician examiners. Arch Gen Psychiatry 1987; 44: 1069–77.
148. Vandiver T, Sher KJ. Temporal stability of the Diagnostic Interview Schedule. Psychol Assess 1991; 3: 277–81.
149. Eaton WW, Neufeld K, Chen LS, Cai G. A comparison of self-report and clinical diagnostic interviews for depression: Diagnostic Interview Schedule and Schedules for Clinical Assessment in Neuropsychiatry in the Baltimore Epidemiologic Catchment Area follow-up. Arch Gen Psychiatry 2000; 57: 217–22.
150. First MB, Spitzer RL, Williams JBW, Gibbon M. User’s Guide for the Structured Clinical Interview for the DSM-IV Axis I Disorders: SCID –I clinician version (Washington, DC: American Psychiatric Press, 1997).
151. First MB, Gibbon M, Williams JBW, Spitzer RL. SCID Screen Patient Questionnaire Computer Program (North Tonawanda, NY: Multi-Health Systems, 2000).
152. Williams JB, Gibbon M, First MB, et al. The Structured Clinical Interview for DSM-III-R (SCID) II: Multisite test-retest reliability. Arch Gen Psychiatry 1992; 49: 630–6.
153. Kerns, R.D. Psychosocial factors: Primary or secondary outcomes? In Pain Treatment Centers at a Crossroads: A Practical Conceptual Reappraisal, eds. JN Campbell and MJ Mitchell. (Seattle: IASP Press, 1996).